A. Company Overview & Capabilities
What is Keron Lifesciences Pvt. Ltd.?
Keron Lifesciences is a pharmaceutical contract manufacturing organization (CMO) based in Dehradun, Uttarakhand, India, providing end-to-end manufacturing solutions for human and animal healthcare products.
What types of pharmaceutical products does Keron Lifesciences manufacture?
The company manufactures tablets, capsules, ointments, and liquid formulations for both human and animal health applications.
What services does Keron Lifesciences offer?
Services include contract manufacturing, third-party manufacturing, formulation development, technology transfer, scale-up, and regulatory support.
Where is Keron Lifesciences’ manufacturing facility located?
The facility is located in Sara Industrial Estate, Rampur, Selaqui, Dehradun, Uttarakhand.
Does Keron Lifesciences support both human and animal healthcare?
Yes, the company has dedicated capabilities for manufacturing pharmaceutical products for both human and animal healthcare applications.
What is the minimum order quantity (MOQ) for contract manufacturing?
MOQs depend on the dosage form and batch size requirements. Partners should discuss their volume requirements with the Keron team to determine feasibility.
How does Keron Lifesciences handle technology transfer?
Technology transfer is managed through a documented, risk-based process that transfers product knowledge and validated methods, followed by process validation stages to ensure commercial-scale consistency.
Can Keron manufacture human and animal health products in the same facility?
Yes, but manufacturing is strictly segregated in different areas according to GMP requirements to prevent cross-contamination between product categories.
Does Keron Lifesciences have in-house R&D capabilities?
Yes, the company provides formulation development support, including pre-formulation studies, compatibility assessments, and ready-to-launch formulations.
What is Keron Lifesciences’ approach to cleaning validation?
Cleaning procedures are validated to ensure no residue from a previous product remains on equipment, preventing cross-contamination between batches.
B. Quality Assurance & Compliance
What quality standards does Keron Lifesciences follow?
Keron operates under WHO-GMP standards and follows a Quality Management System aligned with Schedule M and ICH Q10 guidelines.
How does Keron ensure the quality of raw materials?
All raw materials are sourced from verified suppliers and undergo rigorous QC testing before approval. Incoming materials are quarantined until cleared by QC.
What is the role of Quality Assurance (QA) at Keron Lifesciences?
QA focuses on preventing defects by designing robust processes, including SOP management, vendor qualification, equipment validation, and data integrity (ALCOA+).
What is the role of Quality Control (QC) at Keron Lifesciences?
QC verifies products through rigorous testing, including raw material analysis, in-process testing, finished product evaluation, stability testing, and microbiological testing.
How does Keron ensure batch traceability?
Every batch has a unique identification number linked to comprehensive documentation covering raw material sources, production stages, QC outcomes, and packaging details.
Does Keron Lifesciences conduct internal audits?
Yes, regular scheduled and unannounced internal audits are conducted, with findings tracked through a formal CAPA (Corrective and Preventive Action) log.
What is Keron’s approach to documentation?
Comprehensive documentation is maintained at every stage of manufacturing, testing, and distribution to ensure transparency, accountability, and audit readiness.
What is the difference between QA and QC at Keron?
QA prevents defects by designing robust processes. QC tests and verifies the final product and raw materials against specifications. After the QA validates all the process of internal recordings in all the related functions of Production, QC & QA, the goods are finally released to the customer. The activity has been quite stringent post the new Management and the Leadership joined since June 2025.
How does Keron handle an Out-of-Specification (OOS) result?
An OOS result triggers a formal investigation. The batch is quarantined, and root-cause analysis is conducted. The batch is not released until the investigation is closed and QA approves.
How does Keron ensure data integrity in its laboratories?
The company follows ALCOA+ principles for all documentation, and electronic systems have audit trails to track changes.
What is a Certificate of Analysis (COA), and does Keron provide it?
A COA lists the results of all QC tests performed on a batch. Keron issues a COA with every batch, detailing actual test results against specifications.
What is the role of a Qualified Person (QP) at Keron?
The QP (or equivalent QA authority) reviews batch manufacturing records and analytical results to certify that a batch meets all specifications before release.
How does Keron manage change control?
Any proposed changes to processes, equipment, or documentation go through a formal change control procedure. The impact is assessed, and QA approval is required before implementation.
What is Keron’s policy on sub-contracting manufacturing?
Any sub-contracting is managed through formal quality agreements to ensure that the sub-contractor also complies with GMP standards.
C. Manufacturing & Operations
How does Keron ensure product stability?
Routine stability testing is conducted under varying environmental conditions to determine shelf life and ensure products remain safe and effective. Stability data and products are kept at the facility as per the norms of the GMP standards.
Does Keron have modern manufacturing infrastructure?
Yes, the facility includes controlled production areas, cleanroom environments, in-house QC laboratories, and batch-wise inspection and validation systems.
How does Keron handle deviations or quality events?
Deviations are documented, risk-assessed, investigated using root-cause analysis, and dispositioned by QA before batch release. CAPA measures are implemented to prevent recurrence.
What is Keron’s approach to risk management?
Structured risk management systems identify, evaluate, and control potential risks related to materials, equipment, processes, and product quality.
How does Keron ensure consistency across multiple batches?
Consistency is achieved through validated processes, strict adherence to SOPs, in-process controls, and qualified equipment. Batch records confirm identical production conditions.
Does Keron manufacture fixed-dose combination (FDC) products?
Yes, formulation development services include FDC formulations, supported by appropriate therapeutic justification and compatibility studies.
How does Keron handle temperature-sensitive materials?
The facility has controlled storage areas with defined temperature and humidity conditions. Materials are monitored and stored according to their specific requirements. Readings and recordings are recorded and monitored regularly.
What is Keron’s approach to sustainable manufacturing?
The company uses energy-efficient HVAC systems, water conservation (recycling, rainwater harvesting), and responsible waste management (solvent recovery, recycling).
D. Regulatory & Export
Does Keron Lifesciences export its products?
Yes, the company serves domestic and selected international markets, including Kuwait, Africa, and South Korea (where they manufacture for their customers), and is expanding its global footprint.
What regulatory support does Keron provide?
Support includes DCGI and CDSCO approvals, State FDA licensing, GMP certification, and export NOC documentation.
What documentation is required for exporting pharmaceuticals?
Export documentation includes Certificate of Analysis (COA), Batch Manufacturing Records (BMR), Stability reports, Product dossiers, and Export NOCs.
What is the difference between WHO-GMP and Schedule M?
WHO-GMP refers to international WHO guidelines. Schedule M is the Indian regulatory framework under the Drugs and Cosmetics Act. Keron aligns with both.
What is a Certificate of Pharmaceutical Product (CoPP), and does Keron support it?
A CoPP is issued by CDSCO in the WHO-recommended format for exports. Keron provides regulatory support for obtaining CoPPs and other export documentation.
How does Keron handle market-specific regulatory requirements?
The company provides tailored regulatory support, including dossier preparation, product registration, and export NOC documentation for specific destination markets.
E. Partnership & Evaluation
What should a partner look for when auditing Keron Lifesciences?
Partners should evaluate the WHO-GMP certificate (checking dosage form coverage), sample COA, BMR discipline, and the robustness of deviation/CAPA and OOS investigation procedures.
Does Keron allow client audits of its facility?
Yes, client audits are a standard part of contract manufacturing partnerships. Keron supports facility audits to demonstrate its quality systems and GMP compliance.
What is Keron’s approach to supply chain reliability?
The company qualifies and audits its suppliers of raw materials and packaging components to ensure a reliable supply chain and consistent quality.
How does Keron handle complaints or product recalls?
A defined procedure handles complaints and potential recalls. Complaints are investigated, and if a defect is confirmed, a recall procedure is initiated per regulatory requirements.
What is the typical lead time for a contract manufacturing project?
Lead times vary by product complexity, batch size, and regulatory requirements. Keron works with partners to define realistic timelines during project initiation.
Can Keron assist with product dossier preparation?
Yes, regulatory support services include assistance with preparing and compiling product dossiers for market authorization applications.
